The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jan. 20, 2026

Filed:

May. 01, 2025
Applicants:

Leidos Biomedical Research, Inc., Frederick, MD (US);

Lawrence Livermore National Security, Llc, Livermore, CA (US);

Theras, Inc., South San Francisco, CA (US);

Inventors:

Bin Wang, Dallas, TX (US);

Rui Xu, Dallas, TX (US);

Eli Wallace, Loveland, CO (US);

Zuhui Zhang, Millbrae, CA (US);

David Michael Turner, Frederick, MD (US);

Anna Elzbieta Maciag, Frederick, MD (US);

Dhirendra Kumar Simanshu, Frederick, MD (US);

Albert Hay Wah Chan, Frederick, MD (US);

Tao Liao, Frederick, MD (US);

Christopher John Brassard, Frederick, MD (US);

Yue Yang, Foster City, CA (US);

Paola Bisignano, San Francisco, CA (US);

Felice Lightstone, Fremont, CA (US);

Assignees:

Leidos Biomedical Research, Inc., Frederick, MD (US);

Lawrence Livermore National Security, LLC, Livermore, CA (US);

TheRas, Inc., South San Francisco, CA (US);

Attorneys:
Primary Examiner:
Int. Cl.
CPC ...
C07D 239/80 (2006.01); A61K 31/517 (2006.01); A61K 31/551 (2006.01); C07D 409/04 (2006.01); C07D 409/14 (2006.01); C07D 413/14 (2006.01); C07D 417/04 (2006.01); C07D 417/14 (2006.01); C07D 471/08 (2006.01); C07D 471/10 (2006.01); C07D 487/04 (2006.01); C07D 487/10 (2006.01); C07D 519/00 (2006.01);
U.S. Cl.
CPC ...
C07D 487/10 (2013.01); A61K 31/517 (2013.01); A61K 31/551 (2013.01); C07D 409/04 (2013.01); C07D 409/14 (2013.01); C07D 413/14 (2013.01); C07D 417/04 (2013.01); C07D 417/14 (2013.01); C07D 471/08 (2013.01); C07D 471/10 (2013.01); C07D 487/04 (2013.01); C07D 519/00 (2013.01);
Abstract

Provided herein are compounds, or salts, esters, tautomers, prodrugs, zwitterionic forms, or stereoisomers thereof, as well as pharmaceutical compositions comprising the same. Also provided herein are methods of using the same in modulating (e.g., inhibiting) KRAS (e.g., KRAS having a G12C mutation) and treating diseases or disorders such as cancers in subjects in need thereof.


Find Patent Forward Citations

Loading…